News for 'Drugs Technical Advisory'

2nd wave subsiding, but can't say worst is over: Govt

2nd wave subsiding, but can't say worst is over: Govt

Rediff.com17 Oct 2021

Cautioning that the country is passing through a phase when there are festivals and potential gatherings, he said this is a critical phase as the virus can spread again.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

E-cigarettes: The damage is worse than you think!

E-cigarettes: The damage is worse than you think!

Rediff.com13 Nov 2019

E-cigarettes pose a huge health risk to users, who more often than not are adolescents and young adults

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Soumya Swaminathan: Just what the doctor ordered

Soumya Swaminathan: Just what the doctor ordered

Rediff.com14 Oct 2017

Her appointment as World Health Organisation's deputy director offers an opportunity to push for improving the medical research environment in India.

Covid fight not over, be satark, saavdhan: Modi at high-level review meeting

Covid fight not over, be satark, saavdhan: Modi at high-level review meeting

Rediff.com23 Dec 2021

Modi gave directions to officials during a high-level meeting to review the status of COVID-19 and Omicron, the new variant of concern (VOC), and said "we should be 'satark' (vigilant) and 'saavdhan' (cautious)".

Should Children Get COVID-19 Vaccine?

Should Children Get COVID-19 Vaccine?

Rediff.com8 Sep 2021

Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.

COVID-19: 'Good behaviour will reduce deaths'

COVID-19: 'Good behaviour will reduce deaths'

Rediff.com27 Aug 2020

'We cannot be naughty and expect the government to do good!' 'We have to behave ourselves and then we can expect the government to support us.' 'If we are able to protect ourselves well, then we should not be having deaths.' 'Unfortunately, people have gotten into this super scary event participation (mode) -- birthday parties, large gatherings.' 'Among the people who have attended those, 80 to 90 per cent of them have come down with COVID-19.'

'The psychological impact of layoffs is often forgotten'

'The psychological impact of layoffs is often forgotten'

Rediff.com6 Oct 2014

But when organisations cushion the impact to make it less traumatic, it helps in the recovery process, Wayne F Cascio tells Abhilasha Ojha

How India botched up its war against COVID-19

How India botched up its war against COVID-19

Rediff.com10 May 2021

India is in the midst of its biggest crisis since Independence. It is a national emergency and begs to be dealt with. Politics can wait. Lives need to be saved. We need to vaccinate India at a pace faster than any country in the world, asserts Ramesh Menon.

8 exciting tech careers for Indian engineers

8 exciting tech careers for Indian engineers

Rediff.com11 Feb 2020

There is a high demand for IT professionals who can envision, design and develop applications for the future.

Sensex, Nifty climb 1% as oil prices rally

Sensex, Nifty climb 1% as oil prices rally

Rediff.com18 Feb 2016

Bank shares were the top gainer in early trades with Bank of Baroda up over 4%.

Bears take a breather as Chinese markets stabilise

Bears take a breather as Chinese markets stabilise

Rediff.com8 Jan 2016

Markets across the globe gained after China Securities Regulator removed its four-day-old circuit-breaker system.

Markets finish higher for 5th straight session; oil, metals shine

Markets finish higher for 5th straight session; oil, metals shine

Rediff.com6 Oct 2015

Markets across the globe are rallying on hopes that the US Federal Reserve won't lift interest rates until 2016.

Markets end higher amid volatility; IT shares shine, banks slide

Markets end higher amid volatility; IT shares shine, banks slide

Rediff.com17 Jul 2015

Sensex climbs higher on favourable global cues.

Sensex rises, Nifty ends at record high; RIL shares rally

Sensex rises, Nifty ends at record high; RIL shares rally

Rediff.com3 Mar 2015

Sensex rises, Nifty ends at record high; RIL shares rally.

How India is keeping Ebola out

How India is keeping Ebola out

Rediff.com27 Oct 2014

India has so far succeeded in staving off the deadly virus that has claimed over 4,500 lives abroad.

« Prev  |